Evidence map›Paper›PMID 26779559›Full record

ArticleTobacco regulatory science

Characterization of SPECTRUM Variable Nicotine Research Cigarettes.

Patricia Richter, Pappas R Steven, Roberto Bravo, Joseph G Lisko, Maria Damian, Nathalie Gonzalez-Jimenez, Naudia Gray, Lisa M Keong, Jacob B Kimbrell, Peter Kuklenyik and 8 more

Open access · diamondAbstract read
In one paragraph

Article in Tobacco regulatory science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Pooled it
  3. Trial
  4. An Evaluation of Potential Unintended Consequences of a Nicotine Product Standard: A Focus on Drinking History and Outcomes.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Trial
  5. Switching to Progressively Reduced Nicotine Content Cigarettes in Smokers With Low Socioeconomic Status: A Double-Blind Randomized Clinical Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Trial
  6. Smoking Topography Characteristics During a 6-Week Trial of Very Low Nicotine Content Cigarettes in Smokers With Serious Mental Illness.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Trial
  7. Trial
  8. The Impact of Gradual and Immediate Nicotine Reduction on Subjective Cigarette Ratings.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Carcinogenic components of tobacco and tobacco smoke: A 2022 update.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2022
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Patricia RichterTobacco and Volatiles Branch, Centers for Disease Control and Prevention, Atlanta, GA.
Pappas R StevenTobacco and Volatiles Branch, Centers for Disease Control and Prevention, Atlanta, GA.
Roberto BravoTobacco and Volatiles Branch, Centers for Disease Control and Prevention, Atlanta, GA.
Joseph G LiskoTobacco and Volatiles Branch, Centers for Disease Control and Prevention, Atlanta, GA.
Maria DamianBattelle Analytical Services, Atlanta, GA.
Nathalie Gonzalez-JimenezOak Ridge Institute for Science and Education, Oak Ridge, TN.
Naudia GrayTobacco and Volatiles Branch, Centers for Disease Control and Prevention, Atlanta, GA.
Lisa M KeongBattelle Analytical Services, Atlanta, GA.
Jacob B KimbrellOak Ridge Institute for Science and Education, Oak Ridge, TN.
Peter KuklenyikCenters for Disease Control and Prevention, Atlanta, GA.
Tameka S LawlerTobacco and Volatiles Branch, Centers for Disease Control and Prevention, Atlanta, GA.
Grace E LeeTobacco and Volatiles Branch, Centers for Disease Control and Prevention, Atlanta, GA.
Magaly MendezTobacco and Volatiles Branch, Centers for Disease Control and Prevention, Atlanta, GA.
Jose PerezTobacco and Volatiles Branch, Centers for Disease Control and Prevention, Atlanta, GA.
Shakia SmithOak Ridge Institute for Science and Education, Oak Ridge, TN.
Hang TranTobacco and Volatiles Branch, Centers for Disease Control and Prevention, Atlanta, GA.
Robert TyxTobacco and Volatiles Branch, Centers for Disease Control and Prevention, Atlanta, GA.
Clifford H WatsonTobacco and Volatiles Branch, Centers for Disease Control and Prevention, Atlanta, GA.
Oak Ridge Institute for Science and EducationCenters for Disease Control and Prevention · USOak Ridge Associated Universities · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectiveTo provide researchers an extensive characterization of the SPECTRUM variable nicotine research cigarettes.

methodsData on cigarette physical properties, nicotine content, harmful and potentially harmful constituents in the tobacco filler was compiled.

resultsData on physical properties, concentrations of menthol, nicotine and minor alkaloids, tobacco-specific nitrosamines, polycyclic aromatic hydrocarbons, ammonia, and toxic metals in the filler tobacco for all available varieties of Spectrum research cigarettes are provided. The similarity in the chemistry and physical properties of SPECTRUM cigarettes to commercial cigarettes renders them acceptable for use in behavioral studies. Baseline information on harmful and potentially harmful constituents in research tobacco products, particularly constituent levels such as minor alkaloids that fall outside typical ranges reported for commercial, provide researchers with the opportunity to monitor smoking behavior and to identify biomarkers that will inform efforts to understand the role of nicotine in creating and sustaining addiction.

conclusionsWell characterized research cigarettes suitable for human consumption are an important tool in clinical studies for investigating the physiological impacts of cigarettes delivering various levels of nicotine, the impact of reduced nicotine cigarettes on nicotine addiction, and the relationship between nicotine dose and smoking behavior.

Indexed as

alkaloidscigarettesmetalsnicotinePAHspectrumtobacco

Identifiers

PMID26779559
PMCPMC4711912
OpenAlexW2314833283

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.